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Abstract: Numerous host and viral factors are capable of causing death of HIV infected cells, uninfected bystander cells, 
or both. We assessed the relevance of HIV protease in infected cell killing by mutating its obligate substrate for death, 
procaspase 8. VSV pseudotyped HIV infection of cells expressing WT caspase 8 resulted in apoptotic cell death and 
generation of the HIV protease specific cleavage product of procaspase 8, casp8p41. Conversely, both cell death and 
casp8p41 production were inhibited in cells expressing procaspase 8 engineered to be resistant to HIV protease cleavage. 
Lymph nodes from HIV-infected patients with ongoing viral replication also selectively expressed casp8p41, which colo-
calized with both infected and apoptotic cells. HIV protease cleavage of procaspase 8 appears to be a necessary event for 
infected cell killing, which is responsible for infected cell death within lymphoid tissues from HIV-infected patients. 
INTRODUCTION 
  Numerous factors associated with HIV infection are ca-
pable of causing cell death. Broadly, these can be catego-
rized as viral proteins capable of initiating or modifying cell 
death pathways including Tat, env, Vpr and protease or host 
factors which are modified in a manner which favors cell 
death including Fas/Fas ligand, TNF/TNF receptor 1, and/or 
TRAIL/TRAIL receptor 1 or 2 (reviewed in [1]). Both cells 
that are directly infected by HIV as well as neighboring un-
infected cells die following HIV infection. Potential stimuli 
which initiate uninfected bystander cell death include soluble 
Tat, env, and Vpr or death-inducing ligands produced by 
infected cells acting in trans upon uninfected targets. In real-
ity, it is likely that all of these stimuli cooperatively contrib-
ute to the cumulative bystander cell death. 
  Unlike the situation with uninfected cell death, the mo-
lecular stimuli responsible for infected cell death are even 
less well understood. Such death has been variably described 
as being lytic or direct cytotoxicity, although the majority of 
the investigations conclude that infected cells die through 
apoptosis as evidenced by caspase activation, TUNEL posi-
tivity, PARP cleavage, etc (reviewed in [2]). However, even 
this conclusion remains controversial due to a series of find-
ings where cell lines deficient in selected apoptosis regula-
tory proteins were infected with HIV and analyzed for death. 
Since cell death still occurred in cells deficient in RIP, pro-
caspase 8, and FADD, the authors concluded that such death 
must be necrotic with apoptotic features [3]. It is noteworthy 
that even under the conditions examined, 10-15% apoptosis 
was observed, and therefore the authors acknowledged that 
HIV infection may directly cause loss of mitochondrial 
transmembrane potential and release of apoptogenic factors, 
similar to what has subsequently been described for HIV Vpr  
[4]. In addition, these authors acknowledged that HIV infec- 
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tion might also have a direct effect on caspases, consistent 
with the known effect of HIV protease on procaspase 8 [5, 
6]. Indeed, further evidence of a direct role for apoptosis, but 
not necrosis in infected cell death is found using the pan-
caspase inhibitor Z-VAD FMK, which significantly reduces 
infected cell death [7], and correlations between rates of HIV 
disease progression and levels of HIV induced apoptosis [8-
10]. 
  HIV protease (PR), unlike other HIV proteins, can only 
cause death of infected, but not uninfected cells. The sub-
strate specificity of PR is sufficiently degenerate that HIV 
protease activity which is present within the cytosol of in-
fected cells causes cleavage of a wide variety of host pro-
teins including actin, laminin, Bcl-2, e1F4G, and procaspase 
8 (reviewed in [11]). Of these, procaspase 8 is necessary for 
protease induced cell death since its absence abrogates HIV 
protease induced mitochondrial depolarization and nuclear 
fragmentation [5]. The relevance of HIV protease to infected 
cell killing however is unknown since conflicting data exist 
concerning the involvement of protease in infected cell 
death. Heterologous expression of the HIV genome with stop 
mutations introduced throughout the open reading frames of 
each HIV protein suggest that protease expression is dispen-
sable for HIV-induced killing, yet in those experiments other 
HIV proteins, which are known to independently kill, were 
being overexpressed simultaneously [12]. Other data demon-
strating HIV protease-specific cleavage fragments of pro-
caspase 8, which co-localize with both infected and dying 
cells, argue a more causal role for HIV protease in infected 
cell death [6]. We have previously shown that HIV protease 
alone induces cell death through procaspase 8 cleavage pro-
ducing Casp8p41. The purpose of the current study was to 
determine whether protease cleavage of Caspase 8 occurs 
during acute T cell infection and whether this contributes to 
the overall killing of T cells directly infected with HIV. 
MATERIALS AND METHODS 
Mutagenesis 
  Plasmid pcDNA3Flag-caspase8-Myc [5] harboring 
Arg355Asn356 substitution for Phe355Phe356 was created 2    The Open Virology Journal, 2008, Volume 2  Nie et al. 
by site-directed mutation using Quickchange Site-directed 
Mutagenesis Kit (Strategene). 
Induction of Apoptosis 
  I9.2 cells or I9.2 cells reconstituted with either WT pro-
caspase 8 or procaspase 8 containing the RN mutations at 
positions 355, 356 (10
6) were treated with 10 μM campothe-
cin, 100 ng/ml SuperKillerTRAIL
TM  (Axxora), 250 ng/ml 
anti-Fas antibody CH-11 (Upstate Cell Signaling Solutions), 
50 ng/ml TNF- (R&D Systems) plus 5 μg/ml cyclohexi-
mide, 2 μM HIV Tat (NIH AIDS Research and Reference 
Reagent Program), 1 μg/ml of HIV gp120 (ImmunoDiagnos-
tic), or vehicle controls for 8 h at 37ºC. For Vpr-induced 
apoptosis, cells were incubated with isotonic glucose-Hepes 
buffer
 (2.4% glucose, 13 mM Hepes, 68 mM NaCl, 1.3 mM 
KCl, 4 mM Na2HPO4,
 and 0.7 mM KH2PO4, pH 7.2) alone 
or containing 10 M of Vpr-derived peptide (amino acids 
61-75) (NIH AIDS Research and Reference Reagent Pro-
gram) for 4 h at 37ºC. After the incubation, cells were 
washed in PBS and incubated overnight at 37ºC. 
Electroporation 
 10
7 of each stable I9.2 clone was transfected with 10 ug 
of HIV protease gene cloned into pEYFP-C1 or vector con-
trol using a BTX Electro Square Porator T820 (320 volts, 20 
msec) in 0.3 mls serum free media. The cells were washed 
with media, and then cultured in media with 10% FBS at a 
concentration of 2 x 10
6 / ml. After 4 hours, the cells were 
assayed for viability. 
Measurement of Apoptosis 
  Apoptosis was measured by annexin V PE and TUNEL 
staining. In annexin-V staining assay, 1 x 10
6 cells were har-
vested, washed, and stained with 2 l annexin-V PE (BD 
Pharmingen, San Diego, CA) at 37˚C for 20 minutes. 
TUNEL staining for detection of apoptosis is according to 
the manufacturer’s protocol (Roche, Nutley, NJ). Flow cy-
tometry was performed using a FACScan (Becton Dickinson 
Immunocytometry Systems, San Jose, CA), and analysis was 
done using CellQuest software. 
VSV-g Infections 
  VSV-g pseudotyped HIV virus stock were prepared, as 
we have previously described [4]. Briefly, 5g HIV-
1HxBRUVpr-Env- and 10 g VSV-g plasmids (the ratio 1:2) 
were co-transfected into 293 T cells. The pseudotyped HIV 
viruses were concentrated by centrifugation and titrated by 
the multinuclear activation of galactosidase indicator 
(MAGI) assay. The I9.2 cells reconstituted by caspase 8 wt 
and RN mutant were infected at a MOI of 10. The infected 
cells (10
4 cells/per sample) were harvested each 12 hr post-
infection for ATP activity assay (ATP-Glo Bioluminometric 
Cell Viability Assay Kit. 
Casp8p41 Staining 
  To determine the presence of casp8p41 in apoptotic cells, 
cells were fixed in 2% paraformaldehyde at 4ºC overnight, 
then permeabilized with PBS +0.1% NP-40 on ice for 2 
minutes. Cells were then incubated with the mouse anti-
casp8p41 antibody followed, by PE-labeled goat anti-mouse 
antibody (Becton Dickinson ImmunoCytochemistry) and 
FITC-labeled rabbit anti-active caspase 3 antibody. 
Patient Samples 
  Patient samples were obtained from the National Disease 
Research Interchange (NDRI). Immunohistochemistry on 
frozen sections was done as previously described [13] using 
the following antibodies: anti-P24 FITC, anti-active caspase 
3 FITC, and anti-caspase8p41 PE, plus goat a Mo IgG-PE. 
This protocol was reviewed and approved by the Mayo 
Clinic Institutional Review Board. 
RESULTS 
HIV Protease-Induced T Cell Death Requires WT Pro-
caspase 8 
  We have previously mapped the site where HIV protease 
cleaves procaspase 8 as being between phenylalanines at 
positions 355 and 356, and showed that mutating these resi-
dues to Arg (R) and Asn (N), respectively, prevents protease 
cleavage [6] (Fig. 1). On the basis of this finding, we have 
now reconstituted procaspase 8 expression in I9.2 cells, 
which are normally deficient in procaspase 8 with either WT  
 
 
Fig. (1). S
35 wild-type procaspase 8 or procaspase 8 with mutations 
F355R, F356N were mixed with varying amounts of protease and 
analyzed by autoradiography for cleavage. Wild-type procaspase 8 
incubated with HIV-PR resulted in a 41 kd band that was much less 
evident in the RN mutant. Results are representative of three inde-
pendent experiments. 
procaspase 8, or the RN procaspase 8 mutant in order to in-
vestigate the role of protease in HIV induced killing (Fig. 
2A). Since procaspase 8 is involved in the apoptotic signal-
ing induced by a breadth of stimuli, we assessed the apop-
totic response of I9.2 cells reconstituted by either wild-type 
procaspase 8 or the RN procaspase 8 mutant. The viability of 
untreated I9.2 cells over expressing either WT procaspase 8 
or RN procaspase 8 mutant was consistently more than 95%. 
The stimuli we tested included stimuli which had been im-
plicated in cell death associated with HIV infection including 
Tat, gp120, nef, Vpr, Fas ligation, TNF and TRAIL (Fig. 
2B). Consistent with procaspase 8 signaling being involved 
in cell death induced by Tat, Fas ligand, TNF, TRAIL and 
Env, I9.2 cells stably transfected with vector control under-
went minimal cell death in response to these stimuli. How-
ever, when these cells were reconstituted with either wild-
type procaspase 8 or the RN mutant of procaspase 8, death in 
response to these stimuli was restored, indicating that the RN 
mutant of procaspase 8 signals normally in response to these 
death stimuli. Moreover, vector control, WT procaspase 8, 
and RN procaspase 8 expressing I9.2 cells died equally in 
response to the caspase 8 independent stimuli, Vpr and H2O2. 
However, HIV protease resulted in significant cell death 
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only in I9.2 cells stably expressing WT procaspase 8, but not 
control I9.2 or I9.2 cells expressing RN procaspase 8. There-
fore, cell death induced by HIV protease requires cleavage of 
procaspase 8. Furthermore, the HIV protease cleavage resis-
tant RN procaspase 8 mutant undergoes death signaling 
normally in response to all stimuli tested other than HIV 
protease. 
HIV Induced Cell Death Requires WT Procaspase 8 
  The cleavage of procaspase 8 by HIV protease generates 
a unique fragment of procaspase 8, which is not produced 
following other death stimuli, called casp8p41 [6]. Using a 
monoclonal antibody that specifically recognizes the car-
boxyl terminus of casp8p41 and does not recognize either 
full-length procaspase 8 or other caspase 8 processing inter-
mediates, which are produced during apoptosis induced by 
other stimuli [6], allows assessment of when HIV protease 
has cleaved procaspase 8. Since I9.2 cells have low level 
expression of CD4 (data not shown), robust HIV infection is  
 
not possible. Therefore, bulk populations of transfected cells 
were instead infected with VSV-G-pseudotyped HIV. Since 
HIV protease can only kill cells that express protease in-
tracellularly, (i.e., infected cells), we used a high MOI of 10, 
in order to infect a maximal proportion of cells. Infected 
cells were analyzed for viability (Fig. 3A), clonogenic poten-
tial, (Fig. 3B), and for casp8p41 expression (Fig. 3C). Infec-
tion of WT procaspase 8 expressing I9.2 cells results in high 
levels of death as determined by active caspase 3 and high 
expression of casp8p41. As expected, since the procaspase 8 
F355R, F356N mutant is cleaved less by HIV-PR (Fig. 1), 
infection of the RN procaspase 8 expressing I9.2 cells re-
sulted in less casp8p41 production, and remarkably, less 
HIV-induced death. At 60 hours post-infection, I9.2 cells 
reconstituted with WT casp8 were 57% viable, whereas cells 
reconstituted with casp8 RN were 92% viable (p<0.05). 
Thus, introduction of a mutation in procaspase 8 alone is 
sufficient to achieve two endpoints: 1) abrogating the 
caspase8 cleavage by protease, and 2) reducing HIV-induced 
death by blocking production of casp8p41. 
 
Fig. (2). (A) Bulk caspase 8 deficient I9.2 cells were stably transfected with either WT procaspase 8 (WT casp8) or procaspase 8 containing 
the F355R F356N mutant (casp8 RN), and expression of the transgene confirmed by immunoblot for procaspase 8. (B) Bulk 19.2 cells stably 
transfected with GFP, GFP wild-type caspase 8, or GFP RN mutant caspase 8 were treated with Tat, Fas ligation, gp120, TNF, TRAIL, Vpr 
peptide, H202, or transfected with HIV protease and analyzed for death specifically in the GFP positive cells. 
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Fig. (3). ( A) I9.2 cells stably transfected with wild type (WT) 
caspase 8 or caspase 8 with the RN mutation were infected with 
VSV-G pseudotyped HIV and analyzed for viability as a function 
of time by trypan blue exclusion. (B) The stably transfected I9.2 
cells were infected with VSV-G pseudotyped HIV and analyzed for 
relative cell number 60 hours post-infection by ATP activity. (C) 
Cells harvested 60 hours post-infection were also assessed for 
casp8p41 content. Results are representative of three independent 
experiments. 
Procaspase 8 Cleavage to Casp8p41 Occurs In Vivo 
  Having previously shown that HIV protease kills cells 
through Casp8p41 [6], and that cell death induced following 
T cell infection with intact HIV requires procaspase 8 proc-
essing by protease, we next assessed whether Casp8p41 oc-
curs in lymphoid tissues from HIV infected patients. Previ-
ously, we have shown that Casp8p41 is present in PBL from 
HIV infected patients predominantly within the CD4
+ CD27
+ 
memory subset, and that Casp8p41 positive cells were apop-
totic and contained HIV p24, but that only a small percent-
age of PBL contained Casp8p41. Since recent data suggest 
that a significant proportion of T cells that die within lym-
phoid tissues are physically infected with HIV [14], we 
chose to examine lymphoid tissues using immunohistochem-
istry for casp8p41, activated caspase 3 as a marker of apop-
tosis, and p24 as a marker of HIV infection. First we vali-
dated our casp8p41 antibody for use in immunohistochemis-
try by assessing its immunoreactivity against cells trans-
fected with casp8p41, full length caspase8, or the 43Kd 
caspase 8 cleavage intermediate (Fig. 4A). Next, we ana-
lyzed at least three different lymph node sections from HIV 
negative patients, HIV positive patients on suppressive ther-
apy, or HIV positive patients on non-suppressive therapy, for 
casp8p41, in combination with either HIV-p24 or activated 
caspase 3. Consistent with our observations in PBL, 
casp8p41 was detected only in p24 positive infected cells, 
although not all p24 positive cells were casp8p41 positive 
(Fig. 4B). Additionally, all casp8p41 positive cells were ac-
tive caspase 3 positive (Fig. 4C), although not all caspase 3 
positive cells were casp8p41 positive, indicating that by-
stander apoptosis is still present, albeit to lesser degrees. The 
magnitude of casp8p41 staining varied with viral replication; 
in the HIV negative lymph nodes, no casp8p41 was detected; 
in HIV-infected patients on suppressive therapy, few 
casp8p41 positive cells were detected, yet those that were 
stained strongly positive. Finally, in HIV patients on non-
suppressive therapy, an intense casp8p41 staining pattern 
was observed, with a greater number of positive cells per 
section. In all cases, casp8p41 positive cells were p24 posi-
tive and active caspase 3 positive. Importantly, and distinctly 
from our findings in PBL where a minority of cells contained 
casp8p41, in these lymphoid tissues from patients with non-
suppressive HIV therapy a majority of cells within follicular 
areas contain casp8p41. 
DISCUSSION 
  It has been difficult to determine which signals trigger 
death in cells infected by HIV, while these cells are dying. 
We have overcome this obstacle in two ways. Firstly, by 
reconstituting procaspase 8 deficient cells with either wild-
type or a procaspase 8 mutant, and demonstrating that the 
protease cleavage resistant procaspase 8 cells signal nor-
mally in response to all stimuli tested other than protease, 
thereby allowing the conclusion that if HIV cell death is re-
duced in these cells, it must be due to reduced protease initi-
ated death. Secondly, using a neoepitope-specific antibody 
that recognizes only the procaspase 8 fragment produced 
following protease cleavage [6] to demonstrate that the pres-
ence of casp8p41 in patient tissues is a selective marker of 
these infected cells which are undergoing death. 
 
0
20
40
60
80
100
120
12          24         36         48         60    
Hours Post Infection
P
e
r
c
e
n
t
 
V
i
a
b
l
e
 
 
WT casp8
casp 8 RN
R
e
l
a
t
i
v
e
 
C
e
l
l
 
N
u
m
b
e
r
 
(
R
L
U
)
0
2
4
6
8
10
12
14
16
W
T
 
c
a
s
p
 
8
c
a
s
p
 
8
 
R
N
W
T
 
c
a
s
p
 
8
c
a
s
p
 
8
 
R
N 0
5
10
15
20
25
30
35
40
45
50
%
 
C
a
s
p
8
 
p
4
1HIV-Infected Cell Death Requires casp8p41  The Open Virology Journal, 2008, Volume 2    5 
(A) 
 
(B) 
 
GFP Caspase 8
GFP
GFP caspase8 p43
GFP Casp8p41
G
F
P
C
a
s
p
8
p
4
1
D
A
P
I
M
e
r
g
e
HIV+
Off HAART
HIV-
HIV+
On HAART
DAPI
casp8p41-
Alexa 555 p24 - FITC Merge
α6    The Open Virology Journal, 2008, Volume 2  Nie et al. 
  Understanding that HIV protease can kill cells in a 
caspase 8 dependant manner [5], via a casp8p41 intermediate 
[6] has allowed us to assess in our current report, whether 
this process is a necessary event for infected T cell death. 
Indeed using a VSV pseudotyped infection, abrogation of 
procaspase 8 cleavage significantly reduces infected cell 
death. Consequently, death of HIV infected cells occurs in 
an HIV protease, caspase 8 dependent manner. 
  Because the majority of apoptotic cells within lymphoid 
tissues of HIV-infected patients contain casp8p41, this ar-
gues that the majority of cell death in lymphoid tissues oc-
curs in infected, but not bystander cells. This contrasts with 
data that TUNEL-positive apoptotic cells are predominantly 
bystander, but not productively infected cells [15]. That 
study used RNA in situ hybridization with five different ri-
boprobes all of >2KB in length to define productive infec-
tion [16], which was not observed in those TUNEL positive 
cells [15]. Our knowledge of the molecular events of apopto-
sis has increased since that study was published; we now 
know that during the terminal stages of apoptosis, when 
DNA is fragmented and TUNEL assays become positive, a 
variety of apoptotic nucleases are activated, notably DFF40 
and endonuclease G [17]. Since endonuclease G has a sub-
strate preference for RNA and ssDNA over dsDNA [17], 
nascent mRNA transcripts present in apoptotic cell are de-
graded in parallel with the occurrence of nuclear fragmenta-
tion. Therefore, identification of mRNA species of >2KB in 
cells with fragmented (TUNEL positive) nuclei is an unreli-
able approach to demonstrate productive HIV infection, 
since RNA will be degraded at that stage of cell death. 
Therein lies the difficulty of determining whether infected 
and apoptotic cells can be identified. Our conclusion that 
apoptotic cells in lymphoid tissues are predominantly in-
fected and dying by a casp8p41 pathway, but not bystander 
apoptotic pathways, comes from three complementary ob-
servations: 1) casp8p41 is produced only by HIV protease, 
and therefore is present only in infected cells; 2) casp8p41 
colocalizes with HIV p24, and 3) casp8p41 co-localizes with 
active caspase 3. 
CONCLUSIONS 
  The contribution of infected cell death relative to unin-
fected (bystander) cell death during HIV infection remains 
unknown. Certainly, the HIV proteins, Tat, Nef, Env, and 
Vpr, all contribute to an apoptosis-prone state and/or initiate 
uninfected cell death in HIV-infected patients. However, 
identifying HIV protease generated casp8p41 as a dominant 
(Fig. 4) contd….. 
(C) 
 
Fig. (4). (A) Hela cells were transfected with the indicated GFP constructs and stained with anti-casp8p41 PE and DAPI. (B) Lymph node 
sections from HIV negative or HIV infected patients with either suppressed or non-suppressed levels of viral replication were stained with 
anti-casp8p41 (red) and anti-p24 (green) counterstained with DAPI to identify nuclei and analyzed by confocal microscopy. Results repre-
sentative of three or more analyses each. (C) Lymph node sections from HIV negative or HIV infected patients with either suppressed or 
non-suppressed levels of viral replication were stained anti-casp8p41 (red) and anti-active caspase 3 (green) and counterstained with DAPI to 
identify nuclei and analyzed by confocal microscopy. Results representative of three or more analyses each. 
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cause of infected cell death in vitro and within lymphoid 
tissues  in vivo, offers opportunities to study the molecular 
events that favor infected cell death, and why certain cell 
types, including macrophage and dendritic cells, do not die 
following infection. 
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ABBREVIATIONS 
TAT =  Transactivator 
ENV =  Envelope 
Vpr =  Viral  Protein  R 
TUNEL  =  Terminal UTP Nucleotide End Labeling 
PARP  =  Poly ADP Ribase Polymerase 
FADD  =  Fas Associated Death Domain 
RIP  =  Receptor Interacting Protein 
HIV  =  Human Immunodeficiency Virus 
VSV =  Vesicular  Stomatitis  Virus 
TRAIL  =  TNF Related Apoptosis Inducing Ligand 
PBL  =  Peripheral Blood Lymphocyte 
DNA =  Deoxyribonucleic  Acid 
RNA =  Ribonucleic  Acid 
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